The evaluation is the first stage of the treatment process. A gathering of information including psychosocial, developmental, and psychiatric history and current symptomatology helps you and your provider develop a preliminary treatment plan and pertinent diagnosis(s)
This is typically a follow-up appointment from your initial evaluation. Meeting with your provider as determined by your initial treatment plan is paramount to your success in treatment. Medications are reviewed, response to treatment, and continued evaluation is part of this visit
Developmental Testing and Written Reports
Testing is aimed at diagnosis of treating of suspected developmental delays. Concerns regarding possible developmental, social, or academic delay can be addressed with this testing. Testing is inclusive of screening diagnosis for auditory processing or sensory integration issues. The written report is reflective of the comprehensive findings and is often useful for IEP purposes or allied services.
Pharmacogenomic testing can help empower you and your provider by examining your DNA with respect to psychotropic medication metabolism.
Empowering sobriety is the focus of this service. Multi-modular treatment modalities are offered to our patients while they are surrounded by the comfort and a peaceful atmosphere to help patients discover balance within.
An in-depth educational, psychiatric and developmental assessment assists your provider in developing an appropriate educational plan. A holistic educational plan can be inclusive of recommendations for an IEP/504 plan. This service can include expert testimony in administrative court.
Integrative Medicinal Modalities
Integrative medicine is not the same as alternative medicine, which refers to an approach to healing that is utilized in place of conventional therapies, or complementary medicine, which refers to healing modalities that are used to complement allopathic approaches.
Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections is a hypothesis that there exists a subset of children with rapid onset of obsessive-compulsive disorder or tic disorders and these symptoms are caused by group A beta-hemolytic streptococcal infections. The proposed link between infection and these disorders is that an initial autoimmune reaction to a GABHS infection produces antibodies. This autoimmune response can result in a broad range of neuropsychiatric symptoms. PANDAS is a subset of the pediatric autoimmune neuropsychiatric syndrome hypothesis. Pediatric acute-onset neuropsychiatric syndrome (PANS) is a clinically defined disorder characterized by the sudden onset of obsessive-compulsive symptoms or eating restrictions, concomitant with acute behavioral deterioration and/or motor/sensory changes in at least two of seven domains. Those domains are anxiety, emotional lability and/or depression, irritability, aggressive or oppositional behavior, academic decline, cognitive decline, and sleep disruption. The definitive diagnosis also necessitates a course that follows a relapsing–remitting pattern. In the case of post-puberty chronicity residual symptoms and their severity increases.